1. Home
  2. BX vs BSX Comparison

BX vs BSX Comparison

Compare BX & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BX
  • BSX
  • Stock Information
  • Founded
  • BX 1985
  • BSX 1979
  • Country
  • BX United States
  • BSX United States
  • Employees
  • BX N/A
  • BSX N/A
  • Industry
  • BX Investment Managers
  • BSX Medical/Dental Instruments
  • Sector
  • BX Finance
  • BSX Health Care
  • Exchange
  • BX Nasdaq
  • BSX Nasdaq
  • Market Cap
  • BX 132.8B
  • BSX 157.6B
  • IPO Year
  • BX 2007
  • BSX 1992
  • Fundamental
  • Price
  • BX $183.68
  • BSX $98.98
  • Analyst Decision
  • BX Buy
  • BSX Strong Buy
  • Analyst Count
  • BX 17
  • BSX 22
  • Target Price
  • BX $167.88
  • BSX $118.91
  • AVG Volume (30 Days)
  • BX 3.4M
  • BSX 7.3M
  • Earning Date
  • BX 10-16-2025
  • BSX 10-22-2025
  • Dividend Yield
  • BX 2.15%
  • BSX N/A
  • EPS Growth
  • BX 41.09
  • BSX 36.90
  • EPS
  • BX 3.70
  • BSX 1.68
  • Revenue
  • BX $13,505,742,000.00
  • BSX $18,494,000,000.00
  • Revenue This Year
  • BX $1.25
  • BSX $19.75
  • Revenue Next Year
  • BX $27.42
  • BSX $10.98
  • P/E Ratio
  • BX $49.70
  • BSX $58.92
  • Revenue Growth
  • BX 37.02
  • BSX 21.44
  • 52 Week Low
  • BX $115.66
  • BSX $80.64
  • 52 Week High
  • BX $200.96
  • BSX $109.50
  • Technical
  • Relative Strength Index (RSI)
  • BX 67.54
  • BSX 29.50
  • Support Level
  • BX $165.32
  • BSX $104.24
  • Resistance Level
  • BX $186.65
  • BSX $109.50
  • Average True Range (ATR)
  • BX 3.72
  • BSX 2.06
  • MACD
  • BX 1.30
  • BSX -0.88
  • Stochastic Oscillator
  • BX 86.08
  • BSX 6.90

About BX Blackstone Inc.

Blackstone is the world's largest alternative-asset manager with $1.167 trillion in total asset under management, including $860.1 billion in fee-earning assets under management, at the end of March 2025. The company has four core business segments: private equity (26% of fee-earning AUM and 30% of base management fees), real estate (34% and 40%), credit and insurance (32% and 23%), and multi-asset investing (8% and 7%). While the firm primarily serves institutional investors (87% of AUM), it also caters to clients in the high-net-worth channel (13%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: